BlackRock Institutional Trust Company N.A. boosted its position in shares of CVS Health Corporation (NYSE:CVS) by 0.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 29,453,560 shares of the pharmacy operator’s stock after buying an additional 230,250 shares during the period. BlackRock Institutional Trust Company N.A.’s holdings in CVS Health Corporation were worth $2,621,072,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. East Coast Asset Management LLC. boosted its stake in shares of CVS Health Corporation by 0.3% in the second quarter. East Coast Asset Management LLC. now owns 2,431 shares of the pharmacy operator’s stock valued at $233,000 after buying an additional 7 shares during the last quarter. Valley National Advisers Inc. boosted its stake in shares of CVS Health Corporation by 0.5% in the second quarter. Valley National Advisers Inc. now owns 1,790 shares of the pharmacy operator’s stock valued at $171,000 after buying an additional 9 shares during the last quarter. Signature Financial Management Inc. boosted its stake in shares of CVS Health Corporation by 0.3% in the third quarter. Signature Financial Management Inc. now owns 3,400 shares of the pharmacy operator’s stock valued at $303,000 after buying an additional 9 shares during the last quarter. Lourd Capital LLC boosted its stake in shares of CVS Health Corporation by 0.3% in the second quarter. Lourd Capital LLC now owns 3,598 shares of the pharmacy operator’s stock valued at $344,000 after buying an additional 11 shares during the last quarter. Finally, Thompson Davis & CO. Inc. boosted its stake in shares of CVS Health Corporation by 0.5% in the second quarter. Thompson Davis & CO. Inc. now owns 2,606 shares of the pharmacy operator’s stock valued at $249,000 after buying an additional 14 shares during the last quarter. Institutional investors and hedge funds own 80.32% of the company’s stock.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

CVS Health Corporation (NYSE:CVS) opened at 81.98 on Friday. The company’s 50 day moving average price is $79.36 and its 200-day moving average price is $87.47. CVS Health Corporation has a 12-month low of $69.30 and a 12-month high of $106.67. The company has a market capitalization of $87.43 billion, a P/E ratio of 17.57 and a beta of 0.84.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings results on Tuesday, November 8th. The pharmacy operator reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.07. CVS Health Corporation had a return on equity of 17.18% and a net margin of 2.96%. The firm had revenue of $44.60 billion for the quarter, compared to analyst estimates of $45.29 billion. During the same quarter in the previous year, the company posted $1.28 EPS. The business’s revenue was up 15.5% on a year-over-year basis. Equities analysts forecast that CVS Health Corporation will post $5.81 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, February 2nd. Shareholders of record on Tuesday, January 24th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.44%. The ex-dividend date is Friday, January 20th. This is a positive change from CVS Health Corporation’s previous quarterly dividend of $0.43. CVS Health Corporation’s payout ratio is 36.40%.

ILLEGAL ACTIVITY WARNING: “BlackRock Institutional Trust Company N.A. Boosts Position in CVS Health Corporation (CVS)” was originally reported by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this article can be viewed at http://www.watchlistnews.com/blackrock-institutional-trust-company-n-a-boosts-position-in-cvs-health-corporation-cvs/1061177.html.

CVS has been the topic of several research analyst reports. Leerink Swann restated a “buy” rating and set a $105.00 target price on shares of CVS Health Corporation in a report on Wednesday, November 9th. Deutsche Bank AG restated a “hold” rating and set a $99.00 target price (down previously from $108.00) on shares of CVS Health Corporation in a report on Tuesday, October 18th. Guggenheim restated a “buy” rating and set a $90.00 target price (down previously from $115.00) on shares of CVS Health Corporation in a report on Tuesday, November 8th. Argus reiterated a “buy” rating and issued a $85.00 price target (down previously from $120.00) on shares of CVS Health Corporation in a report on Thursday, November 10th. Finally, Vetr cut CVS Health Corporation from a “buy” rating to a “hold” rating and set a $82.61 price target on the stock. in a report on Tuesday, January 3rd. Six analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $101.77.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

5 Day Chart for NYSE:CVS

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.